No profile photo available

Lydia Sauer, MD, Dr med

Languages spoken: English, French, German, Spanish

Academic Information

Departments Adjunct - Ophthalmology & Visual Sciences

Board Certification

  • American Board of Ophthalmology
  • Educational Commission for Foreign Medical Graduates

Education History

Fellowship Associated Retinal Consultants
 Fellow
Residency John A. Moran Eye Center, University of Utah Health
 Resident
Internship University of Utah Health
 Intern
Postdoctoral Training John A. Moran Eye Center, University of Utah Health
 Postdoctoral Researcher
Other Training John A. Moran Eye Center, University of Utah Health
 Clinical Observership
Postdoctoral Training University Hospital Jena
 Dr med
Other Training Private Ophthalmology Practice, Dr. med. K. Klaus
 Clinical Observership
Professional Medical Friedrich-Schiller University School of Medicine
 MD

Selected Publications

Journal Article

  1. Sauer L, Chandler M, Hartnett ME (2023). Extending Peripheral Retinal Vascularization in Retinopathy of Prematurity Through Regulation of VEGF Signaling. Am J Ophthalmol, 260, 190-199.
  2. Sauer L, Vitale AS, Jacoby RS, Hart B, Bernstein PS (2023). FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 WITH AND WITHOUT DIABETES. Retina, 43(9), 1597-1607.
  3. Eade KT, Ansell BRE, Giles S, Fallon R, Harkins-Perry S, Nagasaki T, Tzaridis S, Wallace M, Mills EA, Farashi S, Johnson A, Sauer L, Hart B, Diaz-Rubio ME, Bahlo M, Metallo C, Allikmets R, Gantner ML, Bernstein PS, Friedlander M (2023). iPSC-derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial function. J Clin Invest, 133(9).
  4. Sauer L, Vitale AS, Modersitzki NK, Bernstein PS (2021). LONGITUDINAL FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY ANALYSIS IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 (MacTel). Retina, 41(7), 1416-1427.
  5. Goerdt L, Sauer L, Vitale AS, Modersitzki NK, Fleckenstein M, Bernstein PS (2021). Comparing Fluorescence Lifetime Imaging Ophthalmoscopy in Atrophic Areas of Retinal Diseases. Transl Vis Sci Technol, 10(7), 11.
  6. Vitale AS, Sauer L, Modersitzki NK, Bernstein PS (2020). Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Patients with Choroideremia. Transl Vis Sci Technol, 9(10), 33.
  7. Sauer L, Vitale AS, Milliken CM, Modersitzki NK, Blount JD, Bernstein PS (2020). Autofluorescence Lifetimes Measured with Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) Are Affected by Age, but Not by Pigmentation or Gender. Transl Vis Sci Technol, 9(9), 2.
  8. Hammer M, Schultz R, Hasan S, Sauer L, Klemm M, Kreilkamp L, Zweifel L, Augsten R, Meller D (2020). Fundus Autofluorescence Lifetimes and Spectral Features of Soft Drusen and Hyperpigmentation in Age-Related Macular Degeneration. Transl Vis Sci Technol, 9(5), 20.
  9. Sauer L, Vitale AS, Andersen KM, Hart B, Bernstein PS (2019). FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY (FLIO) PATTERNS IN CLINICALLY UNAFFECTED CHILDREN OF MACULAR TELANGIECTASIA TYPE 2 (MACTEL) PATIENTS. Retina, 40(4), 695-704.
  10. Gantner ML, Eade K, Wallace M, Handzlik MK, Fallon R, Trombley J, Bonelli R, Giles S, Harkins-Perry S, Heeren TFC, Sauer L, Ideguchi Y, Baldini M, Scheppke L, Dorrell MI, Kitano M, Hart BJ, Cai C, Nagasaki T, Badur MG, Okada M, Woods SM, Egan C, Gillies M, Guymer R, Eichler F, Bahlo M, Fruttiger M, Allikmets R, Bernstein PS, Metallo CM, Friedlander M (2019). Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy. N Engl J Med, 381(15), 1422-1433.
  11. Sauer L, Calvo CM, Vitale AS, Henrie N, Milliken CM, Bernstein PS (2019). Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy. Ophthalmol Retina, 3(10), 814-825.
  12. Sauer L, Komanski CB, Vitale AS, Hansen ED, Bernstein PS (2019). Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Eyes With Pigment Epithelial Detachments Due to Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci, 60(8), 3054-3063.
  13. Klemm M, Sauer L, Klee S, Link D, Peters S, Hammer M, Schweitzer D, Haueisen J (2019). Bleaching effects and fluorescence lifetime imaging ophthalmoscopy. Biomed Opt Express, 10(3), 1446-1461.
  14. Andersen KM, Sauer L, Gensure RH, Hammer M, Bernstein PS (2018). Characterization of Retinitis Pigmentosa Using Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO). Transl Vis Sci Technol, 7(3), 20.
  15. Hammer M, Sauer L, Klemm M, Peters S, Schultz R, Haueisen J (2018). Fundus autofluorescence beyond lipofuscin: lesson learned from ex vivo fluorescence lifetime imaging in porcine eyes. Biomed Opt Express, 9(7), 3078-3091.
  16. Sauer L, Andersen KM, Li B, Gensure RH, Hammer M, Bernstein PS (2018). Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) of Macular Pigment. Invest Ophthalmol Vis Sci, 59(7), 3094-3103.
  17. Sauer L, Klemm M, Peters S, Schweitzer D, Schmidt J, Kreilkamp L, Ramm L, Meller D, Hammer M (2017). Monitoring foveal sparing in geographic atrophy with fluorescence lifetime imaging ophthalmoscopy - a novel approach. Acta Ophthalmol, 96(3), 257-266.
  18. Sauer L, Gensure RH, Andersen KM, Kreilkamp L, Hageman GS, Hammer M, Bernstein PS (2018). Patterns of Fundus Autofluorescence Lifetimes In Eyes of Individuals With Nonexudative Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci, 59(4), AMD65-AMD77.
  19. Ramm L, Schwab B, Stodtmeister R, Hammer M, Sauer L, Sprl E, Pillunat LE, Terai N (2017). Assessment of Optic Nerve Head Pallor in Primary Open-Angle Glaucoma Patients and Healthy Subjects. Curr Eye Res, 42(9), 1313-1318.
  20. Sauer L, Peters S, Schmidt J, Schweitzer D, Klemm M, Ramm L, Augsten R, Hammer M (2016). Monitoring macular pigment changes in macular holes using fluorescence lifetime imaging ophthalmoscopy. Acta Ophthalmol, 95(5), 481-492.
  21. Schmidt J, Peters S, Sauer L, Schweitzer D, Klemm M, Augsten R, Mller N, Hammer M (2016). Fundus autofluorescence lifetimes are increased in non-proliferative diabetic retinopathy. Acta Ophthalmol, 95(1), 33-40.
  22. Ramm L, Jentsch S, Peters S, Sauer L, Augsten R, Hammer M (2015). Dependence of diameters and oxygen saturation of retinal vessels on visual field damage and age in primary open-angle glaucoma. Acta Ophthalmol, 94(3), 276-81.
  23. Klemm M, Schweitzer D, Peters S, Sauer L, Hammer M, Haueisen J (2015). FLIMX: A Software Package to Determine and Analyze the Fluorescence Lifetime in Time-Resolved Fluorescence Data from the Human Eye. PLoS One, 10(7), e0131640.
  24. Sauer L, Schweitzer D, Ramm L, Augsten R, Hammer M, Peters S (2015). Impact of Macular Pigment on Fundus Autofluorescence Lifetimes. Invest Ophthalmol Vis Sci, 56(8), 4668-79.

Review

  1. Sauer L, Vitale AS, Modersitzki NK, Bernstein PS (2020). Fluorescence lifetime imaging ophthalmoscopy: autofluorescence imaging and beyond. [Review]. Eye (Lond), 35(1), 93-109.
  2. Sauer L, Li B, Bernstein PS (2019). Ocular Carotenoid Status in Health and Disease. [Review]. Annu Rev Nutr, 39, 95-120.
  3. Sauer L, Andersen KM, Dysli C, Zinkernagel MS, Bernstein PS, Hammer M (2018). Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy. [Review]. J Biomed Opt, 23(9), 1-20.
  4. Dysli C, Wolf S, Berezin MY, Sauer L, Hammer M, Zinkernagel MS (2017). Fluorescence lifetime imaging ophthalmoscopy. [Review]. Prog Retin Eye Res, 60, 120-143.

Case Report

  1. Ronquillo CC, Sauer L, Morgan D, Heckzo JB, Creel DJ, Mamalis N, DeAngelis MM, Hagemann GS, Bernstein PS (2019). ABSENCE OF MACULAR DEGENERATION IN A PATIENT WITH ACERULOPLASMINEMIA. Retina, 39(9), 1824-1828.

Editorial

  1. Sauer L, Bernstein PS (2022). Macular Telangiectasia Type 2 versus Tamoxifen Retinopathy: How to Hit a Diagnostic Bullseye. Ophthalmol Retina, 7(2), 97-100.
  2. Bernstein PS, Sauer L (2019). Fluorescence Lifetime Imaging Ophthalmoscopy: A New Era of Autofluorescence Imaging of the Human Retina. Retina, 39(5), 817-819.